|
CYCN Cyclerion Therapeutics Inc 1755237 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-1,755,000.00 |
| Balance Sheet |
|
Current Assets
|
$1,514,000.00 |
|
Assets
|
$6,930,000.00 |
|
Current Liabilities
|
$1,843,000.00 |
|
Equity
|
$5,087,000.00 |
|
Shares Out
|
4256284.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-2,608,000.00 |
|
Investing Cash Flow
|
$-66,000.00 |
| Market Analysis |
Market Cap
|
$17,323,075.88 |
|
Price
|
$4.07 |
|
BVPS
|
1.20 |
|
PB
|
3.39 |
|
EPS
|
-0.41 |
|
FCF
|
$-2,674,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:59 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:50 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CYCN documents filed with the SEC.
CYCN Filings
Clear
